PHARMASSIST CLARIFEX PH MUD CRM 3.0% 3 % — DIN 02024608
SULFUR : 3 % · NU SKIN INTERNATIONAL, INC. · CREAM · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is PHARMASSIST CLARIFEX PH MUD CRM 3.0%?
PHARMASSIST CLARIFEX PH MUD CRM 3.0% 3 % contains SULFUR : 3 %. It is listed in the Health Canada Drug Product Database under DIN 02024608, held by NU SKIN INTERNATIONAL, INC., supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 22-Aug-1996. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Sulphur in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Sulphur, across 30 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| CLINIQUE LABORATORIES DIST | 3 | 0 | ANTI-ACNE FORMULA FOR MEN, ANTI-ACNE FORMULA-LIGHT, ANTI-ACNE FORMULA-MEDIUM | No marketed DIN |
| CARTER-HORNER CORP. | 2 | 0 | PERSOL ACNE CREAM, PERSOL FORTE ACNE CREAM | No marketed DIN |
| FLAGEOLI LIMITED | 2 | 0 | DRY LO - SULPHUR DRYING LOTION, UNMASKED | No marketed DIN |
| RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | 2 | 0 | CLEARASIL SKIN TONE ACNE CRM MEDICATION, CLEARASIL VANISHING ACNE CRM MEDICATION | No marketed DIN |
| SHISEIDO AMERICA INC | 2 | 0 | 5S BLEMISH TREATMENT, SHISEIDO PURENESS BLEMISH CONTROL CREAM-3% | No marketed DIN |
| STIEFEL CANADA ULC | 2 | 0 | SASTID SOAP FOR STUBBORN ACNE, SULFOXYL LOTION REGULAR | No marketed DIN |
| WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | 2 | 0 | PERNOX CRM, PERNOX CRM LEMON | No marketed DIN |
| ADVANCED RESEARCH LABORATORIES | 1 | 0 | CLEAR LOGIX OIL ABSORBENT ACNE MASK | No marketed DIN |
| NU SKIN INTERNATIONAL, INC. | 1 | 0 | PHARMASSIST CLARIFEX PH MUD CRM 3.0% | No marketed DIN |
| PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC. | 1 | 0 | SOUFRE 100% | No marketed DIN |
| RHONE-POULENC RORER CONSUMER INC. | 1 | 0 | POSTACNE LOTION 2% | No marketed DIN |
| SHISEIDO COMPANY LTD. | 1 | 0 | PURENESS BRAND SPOT CREAM | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 3 % |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Sulphur |
|---|---|
| ATC code | D10AB02 |
| AHFS class | 84:28.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02024608 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2024608 |
| Brand name | PHARMASSIST CLARIFEX PH MUD CRM 3.0% |
| Generic / active ingredient | SULFUR : 3 % |
| Market authorization holder | NU SKIN INTERNATIONAL, INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D10AB02 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D10AB |
| Current status | CANCELLED POST MARKET |
| Status date | 22-Aug-1996 |
| Original market date | 1993-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 30 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| 5S BLEMISH TREATMENT | 3 % | CREAM | SHISEIDO AMERICA INC | CANCELLED POST MARKET | 02239408 |
| ACNE BLEMISH CREAM(SULFUR CREAM) | 4 % | CREAM | BONNE BELL OF CANADA LTD. | CANCELLED POST MARKET | 00692069 |
| ACNOMEL SKIN TONE CREAM | 11 % | CREAM | NUMARK LABORATORIES, INC. | CANCELLED POST MARKET | 01925008 |
| ALMAY TROUBLE SPOTTER ACNE PIMPLE MEDICATION | 5 % | CREAM | ALMAY TORONTO INC. | CANCELLED POST MARKET | 02030845 |
| ANTI-ACNE FORMULA FOR MEN | 3.75 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | 00729744 |
| ANTI-ACNE FORMULA-LIGHT | 1 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | 00695858 |
| ANTI-ACNE FORMULA-MEDIUM | 3.75 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | 00695831 |
| CLEAR LOGIX OIL ABSORBENT ACNE MASK | 10 % | LOTION | ADVANCED RESEARCH LABORATORIES | CANCELLED POST MARKET | 02231521 |
| CLEARASIL SKIN TONE ACNE CRM MEDICATION | .1 % | CREAM | RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | CANCELLED POST MARKET | 00730130 |
| CLEARASIL VANISHING ACNE CRM MEDICATION | 2 % | CREAM | RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | CANCELLED POST MARKET | 00730149 |
2 · Same class — other molecules in ATC D10AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Sulphur | 5S BLEMISH TREATMENT · ACNE BLEMISH CREAM(SULFUR CREAM) · ACNOMEL SKIN TONE CREAM · ALMAY TROUBLE SPOTTER ACNE PIMPLE MEDICATION · +26 more | 30 | 0 | Not in Canada |
| Sulphur, Combinations | ACNE AID GEL · SULFACET R LOTION · SULFACET-R | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D10A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D10AE | Benzoyl Peroxide · Benzoyl Peroxide, Combinations | 214 | 35 |
| D10AD | Adapalene · Adapalene, Combinations · Isotretinoin · Tretinoin · Tretinoin, Combinations · +1 more | 48 | 16 |
| D10AF | Chloramphenicol, Combinations · Clindamycin · Clindamycin, Combinations · Erythromycin, Combinations | 23 | 8 |
| D10AX | Aluminium Oxide · Azelaic Acid · Clascoterone · Dapsone · Various Combinations | 6 | 3 |
| D10AA | Corticosteroids,Combinations For Treatment Of Acne · Methylprednisolone | 3 | 0 |
4 · Fixed-dose combinations with Canadian supply
| Product | Active ingredients | Holder | Status | DIN |
|---|---|---|---|---|
| CABTREO | CLINDAMYCIN PHOSPHATE 1.2 %; ADAPALENE 0.15 %; BENZOYL PEROXIDE 3.1 % | BAUSCH HEALTH, CANADA INC. | MARKETED | 02550423 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.